Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2. The new ...

Perimenopause and ovarian ageing, highlighting the importance of future interventions focused on early detection, ...

He, Q., & Yan, Y. (2025). Data Factor Empowers Economic Resilience: Evidence from China. American Journal of Industrial and ...

Introduction Cognitive impairment is a common consequence after stroke. Intermittent theta burst stimulation (iTBS) has emerged as a promising cognitive therapy. However, traditional iTBS typically ...

This is a list of today's New South Wales Civil and Administrative Tribunal consumer and commercial hearings at Sydney : ...

MTSU women’s basketball is off to a rough start sitting at 4-6 with losses ranging from Tennessee Tech to the University of ...